Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Cytek Biosciences stock (Cytek Biosciences)

Buy Cytek Biosciences stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

Cytek Biosciences is a medical devices business based in the US. Cytek Biosciences shares (CTKB) are listed on the NASDAQ and all prices are listed in US Dollars. Cytek Biosciences employs 637 staff and has a trailing 12-month revenue of around $200.8 million.

Our top picks for where to buy Cytek Biosciences stock

Top pick for advanced traders

Go to site
Get up to $5,000 cash
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

Our pick for transfer bonus

Go to site
Get up to $10,000 cash
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options, with no options contract fees
  • No-cost financial planning and automated investing

Our pick for Investing by theme

Go to site
Earn up to $300 on new deposits
  • Trade $0 commission stocks & ETFs with as little as $1
  • Theme and ETF screener
  • Discover new opportunities with Opto's AI-driven classification system

How to buy Cytek Biosciences stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – CTKB. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy Cytek Biosciences stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 6 of 6
Name Product Ratings Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
Finder Score: 4.4 / 5: ★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
Get $50-$5,000
Competitive, capped options commissions, with a reliable trading platform designed for serious traders.
SoFi Invest®
Finder Score: 4.2 / 5: ★★★★★
SoFi Invest®
Stocks, Options, Mutual funds, ETFs, Alternatives
Get up to $10,000 cash
Commission-free stocks, ETFs and options, with no options per-contract fees. Plus, a no-cost robo-advisor and complimentary access to certified financial planners (CFPs).
Finder Score: 3.1 / 5: ★★★★★
Stocks, ETFs
Earn up to $300
AI-driven thematic investing, with proprietary research, fractional shares and commission-free stocks and ETFs.
Cash App
Finder Score: 3 / 5: ★★★★★
Cash App
Stocks, ETFs, Cryptocurrency
Buy and sell over 1,800 stocks and ETFs commission-free and for as little as $1.
Finder Score: 4.3 / 5: ★★★★★
Stocks, Options, ETFs
Up to 8.10%
Get up to 15 free stocks
No commission stock, ETF and options trades, with $0 equity options contract fees, low margin rates and advanced trading tools.
Finder Score: 4.2 / 5: ★★★★★
Stocks, Bonds, Options, ETFs, Cryptocurrency, Alternatives, Treasury Bills, High-yield cash account
Get up to $10,000 and transfer fees covered
Build a diversified portfolio of stocks, bonds, options, ETFs, crypto and alternative assets, with a high-yield cash account and options contract rebates.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Cytek Biosciences stock price (NASDAQ: CTKB)

Use our graph to track the performance of CTKB stocks over time.

Cytek Biosciences shares at a glance

Information last updated 2024-07-14.
Latest market close$6.15
52-week range$3.80 - $9.87
50-day moving average $5.89
200-day moving average $6.67
Wall St. target price$9.50
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.09

Is it a good time to buy Cytek Biosciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Cytek Biosciences price performance over time

Historical closes compared with the close of $6.15 from 2024-07-19

1 week (2024-07-15) -2.84%
1 month (2024-06-21) 7.33%
3 months (2024-04-22) 6.03%
6 months (2024-01-22) -28.65%
1 year (2023-07-21) -30.90%
2 years (2022-07-22) -48.79%
3 years (2021-07-22) 17
5 years (2019-07-18) N/A

Cytek Biosciences financials

Revenue TTM $200.8 million
Gross profit TTM $101 million
Return on assets TTM -3.06%
Return on equity TTM -2.82%
Profit margin -5.73%
Book value $2.99
Market Capitalization $813.9 million

TTM: trailing 12 months

Cytek Biosciences share dividends

We're not expecting Cytek Biosciences to pay a dividend over the next 12 months.

Cytek Biosciences share price volatility

Over the last 12 months, Cytek Biosciences's shares have ranged in value from as little as $3.8 up to $9.87. A popular way to gauge a stock's volatility is its "beta".

CTKB.US volatility(beta: 1.33)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cytek Biosciences's is 1.327. This would suggest that Cytek Biosciences's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

To put Cytek Biosciences's beta into context you can compare it against those of similar companies.

Cytek Biosciences overview

Cytek Biosciences, Inc. , a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries.

Frequently asked questions

What percentage of Cytek Biosciences is owned by insiders or institutions?
Currently 8.742% of Cytek Biosciences shares are held by insiders and 62.08% by institutions.
How many people work for Cytek Biosciences?
Latest data suggests 637 work at Cytek Biosciences.
When does the fiscal year end for Cytek Biosciences?
Cytek Biosciences's fiscal year ends in December.
Where is Cytek Biosciences based?
Cytek Biosciences's address is: 47215 Lakeview Boulevard, Fremont, CA, United States, 94538
What is Cytek Biosciences's ISIN number?
Cytek Biosciences's international securities identification number is: US23285D1090

More guides on Finder

Ask a question provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site